Research Paper Volume 15, Issue 22 pp 13265—13286
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Figure 2. KLRB1 in relation to clinical features in BC. (A–D) T stage; (E) Pathological stage; (F) Age; (G) Her2 status; (H–J) The better prognosis related the KLRB1 overexpression.